Sweden - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Sweden Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry rose 2.1% year on year. In 2019, the country was ranked number 12 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry with $847,585,097.1 Million PPP. Sweden is overtaken by Italy, which was ranked number 11 at $894,380,465.38 Million PPP and is followed by Taiwan with $581,419,961.53 Million PPP. United States topped the ranking with $70,565,318,932.39 Million PPP in 2019, that is +3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania was the worst growing country at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 847,585,097.10 |
| 2018 | 848,688,917.12 |
| 2017 | 860,688,025.95 |
| 2016 | 828,192,211.79 |
| 2015 | 861,053,987.29 |
How does Sweden rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 11 |
#11
Italy
|
894,380,465.38 | 2019 | +2.0 % | +5.3 % | View data | |
| 12 |
#12
Sweden
|
847,585,097.10 | 2019 | -0.1 % | +2.1 % | View data | |
| 13 |
#13
Taiwan
|
581,419,961.53 | 2019 | +7.2 % | +3.5 % | View data | |